Skip to Content
Merck
CN
  • Development of a microchannel emulsification process for pancreatic beta cell encapsulation.

Development of a microchannel emulsification process for pancreatic beta cell encapsulation.

Biotechnology progress (2019-05-28)
Christina M E Bitar, Karen E Markwick, Dušana Treľová, Zuzana Kroneková, Michal Pelach, Chloé M O Selerier, James Dietrich, Igor Lacík, Corinne A Hoesli
ABSTRACT

In this study, we developed a high-throughput microchannel emulsification process to encapsulate pancreatic beta cells in monodisperse alginate beads. The process builds on a stirred emulsification and internal gelation method previously adapted to pancreatic cell encapsulation. Alginate bead production was achieved by flowing a 0.5-2.5% alginate solution with cells and CaCO3 across a 1-mm thick polytetrafluoroethylene plate with 700 × 200 μm rectangular straight-through channels. Alginate beads ranging from 1.5-3 mm in diameter were obtained at production rates exceeding 140 mL/hr per microchannel. Compared to the stirred emulsification process, the microchannel emulsification beads had a narrower size distribution and demonstrated enhanced compressive burst strength. Both microchannel and stirred emulsification beads exhibited homogeneous profiles of 0.7% alginate concentration using an initial alginate solution concentration of 1.5%. Encapsulated beta cell viability of 89 ± 2% based on live/dead staining was achieved by minimizing the bead residence time in the acidified organic phase fluid. Microchannel emulsification is a promising method for clinical-scale pancreatic beta cell encapsulation as well as other applications in the pharmaceutical, food, and cosmetic industries.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Glyceryl trioleate, ~65%